Elicio Therapeutics, Inc. (ELTX)

Elicio Therapeutics Statistics

Total Valuation

ELTX has a market cap or net worth of $224.43 million. The enterprise value is $220.38 million.

Market Cap	224.43M
Enterprise Value	220.38M

Important Dates

The last earnings date was Thursday, March 12, 2026, after market close.

Earnings Date	Mar 12, 2026
Ex-Dividend Date	n/a

Share Statistics

ELTX has 18.40 million shares outstanding. The number of shares has increased by 25.48% in one year.

Current Share Class	18.40M
Shares Outstanding	18.40M
Shares Change (YoY)	+25.48%
Shares Change (QoQ)	-7.10%
Owned by Insiders (%)	30.90%
Owned by Institutions (%)	12.94%
Float	11.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	132.74
P/TBV Ratio	137.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.38, with a Debt / Equity ratio of 8.87.

Current Ratio	2.38
Quick Ratio	2.29
Debt / Equity	8.87
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-33.29

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-87.24%
Return on Invested Capital (ROIC)	-152.68%
Return on Capital Employed (ROCE)	-212.45%
Weighted Average Cost of Capital (WACC)	13.06%
Revenue Per Employee	n/a
Profits Per Employee	-$1.24M
Employee Count	32
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +55.03% in the last 52 weeks. The beta is 1.68, so ELTX's price volatility has been higher than the market average.

Beta (5Y)	1.68
52-Week Price Change	+55.03%
50-Day Moving Average	9.27
200-Day Moving Average	9.32
Relative Strength Index (RSI)	59.05
Average Volume (20 Days)	153,237

Short Selling Information

The latest short interest is 1.30 million, so 7.07% of the outstanding shares have been sold short.

Short Interest	1.30M
Short Previous Month	1.28M
Short % of Shares Out	7.07%
Short % of Float	11.04%
Short Ratio (days to cover)	8.72

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-37.71M
Pretax Income	-39.57M
Net Income	-39.57M
EBITDA	-37.51M
EBIT	-37.71M
Earnings Per Share (EPS)	-$2.58

Balance Sheet

The company has $18.56 million in cash and $14.51 million in debt, with a net cash position of $4.05 million or $0.22 per share.

Cash & Cash Equivalents	18.56M
Total Debt	14.51M
Net Cash	4.05M
Net Cash Per Share	$0.22
Equity (Book Value)	1.64M
Book Value Per Share	0.09
Working Capital	11.20M

Cash Flow

In the last 12 months, operating cash flow was -$36.95 million and capital expenditures -$16,000, giving a free cash flow of -$36.97 million.

Operating Cash Flow	-36.95M
Capital Expenditures	-16,000
Free Cash Flow	-36.97M
FCF Per Share	-$2.01

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ELTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.48%
Shareholder Yield	-25.48%
Earnings Yield	-17.63%
FCF Yield	-16.47%

Analyst Forecast

The average price target for ELTX is $17.00, which is 37.93% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$17.00
Price Target Difference	37.93%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2